Owens & Minor (NYSE:OMI) Announces Quarterly Earnings Results

Owens & Minor (NYSE:OMI - Get Free Report) released its quarterly earnings data on Friday. The company reported $0.55 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.02, Zacks reports. The firm had revenue of $2.70 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The business's quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.69 earnings per share. Owens & Minor updated its FY25 guidance to $1.60-1.85 EPS and its FY 2025 guidance to 1.600-1.850 EPS.

Owens & Minor Stock Up 4.7 %

Shares of NYSE:OMI traded up $0.44 during trading on Tuesday, hitting $9.76. 4,173,384 shares of the company were exchanged, compared to its average volume of 1,716,829. The stock has a market capitalization of $752.66 million, a P/E ratio of -15.02, a PEG ratio of 0.20 and a beta of 0.48. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. Owens & Minor has a 12-month low of $6.07 and a 12-month high of $28.35. The firm's 50 day moving average price is $11.38 and its 200-day moving average price is $13.14.

Analyst Upgrades and Downgrades

OMI has been the topic of several analyst reports. Robert W. Baird raised their price target on shares of Owens & Minor from $10.00 to $11.00 and gave the company a "neutral" rating in a research report on Monday. UBS Group dropped their price target on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Citigroup dropped their price target on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating on the stock in a research report on Tuesday, November 5th. Finally, Barclays decreased their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating on the stock in a report on Tuesday, November 5th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, Owens & Minor presently has a consensus rating of "Hold" and a consensus price target of $15.08.

Remove Ads

Owens & Minor declared that its Board of Directors has initiated a share repurchase program on Friday, February 28th that permits the company to repurchase $100.00 million in shares. This repurchase authorization permits the company to reacquire up to 13.6% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's leadership believes its shares are undervalued.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.